A. Scott Smith's Insider Trades & SAST Disclosures
A. Scott Smith's most recent trade in Viatris Inc was a trade of 60,000 Common Stock done at an average price of $8.9 . Disclosure was reported to the exchange on May 12, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern A. Scott Smith.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Viatris Inc | Scott A. Smith | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 8.94 per share. | 12 May 2025 | 60,000 | 292,807 (0%) | 0% | 8.9 | 536,262 | Common Stock |
| Viatris Inc | Scott A. Smith | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 373,555 | 373,555 | - | - | Restricted Stock Units | |
| Viatris Inc | Scott A. Smith | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 135,828 | 221,178 (0%) | 0% | 0 | Common Stock | |
| Viatris Inc | Scott A. Smith | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 135,828 | 135,828 | - | - | Restricted Stock Units | |
| Viatris Inc | Scott A. Smith | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 92,503 | 266,825 (0%) | 0% | 0 | Common Stock | |
| Viatris Inc | Scott A. Smith | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 92,503 | 185,006 | - | - | Restricted Stock Units | |
| Viatris Inc | Scott A. Smith | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.33 per share. | 03 Mar 2025 | 53,449 | 167,729 (0%) | 0% | 9.3 | 498,679 | Common Stock |
| Viatris Inc | Scott A. Smith | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.37 per share. | 03 Mar 2025 | 36,400 | 230,425 (0%) | 0% | 9.4 | 341,068 | Common Stock |
| Viatris Inc | Scott A. Smith | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 10,872 | 178,601 (0%) | 0% | 0 | Common Stock | |
| Viatris Inc | Scott A. Smith | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 10,871 | 10,871 | - | - | Dividend Equivalent Units | |
| Viatris Inc | Scott A. Smith | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.33 per share. | 03 Mar 2025 | 4,279 | 174,322 (0%) | 0% | 9.3 | 39,923 | Common Stock |
| Viatris Inc | Scott A. Smith | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 3,928 | 234,353 (0%) | 0% | 0 | Common Stock | |
| Viatris Inc | Scott A. Smith | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 3,927 | 7,854 | - | - | Dividend Equivalent Units | |
| Viatris Inc | Scott A. Smith | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.37 per share. | 03 Mar 2025 | 1,546 | 232,807 (0%) | 0% | 9.4 | 14,486 | Common Stock |
| BioAtla Inc | Scott A. Smith | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.77 per share. | 31 Aug 2024 | 2,181 | 298,050 | - | 1.8 | 3,860 | Common Stock |
| BioAtla Inc | Scott A. Smith | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.81 per share. | 31 Jul 2024 | 2,181 | 300,231 | - | 1.8 | 3,948 | Common Stock |
| BioAtla Inc | Scott A. Smith | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.37 per share. | 30 Jun 2024 | 2,181 | 302,412 | - | 1.4 | 2,988 | Common Stock |
| BioAtla Inc | Scott A. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 16,500 | 304,593 | - | 0 | Common Stock | |
| BioAtla Inc | Scott A. Smith | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.51 per share. | 31 May 2024 | 2,181 | 288,093 | - | 1.5 | 3,293 | Common Stock |
| BioAtla Inc | Scott A. Smith | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.26 per share. | 30 Apr 2024 | 2,181 | 290,274 | - | 2.3 | 4,929 | Common Stock |
| BioAtla Inc | Scott A. Smith | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.44 per share. | 31 Mar 2024 | 2,181 | 292,455 | - | 3.4 | 7,503 | Common Stock |
| Viatris Inc | Scott A. Smith | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2024 | 277,509 | 277,509 | - | - | Restricted Stock Units | |
| Viatris Inc | Scott A. Smith | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2024 | 135,829 | 135,829 (0%) | 0% | 0 | Common Stock | |
| Viatris Inc | Scott A. Smith | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2024 | 135,829 | 271,656 | - | - | Restricted Stock Units | |
| Viatris Inc | Scott A. Smith | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.59 per share. | 03 Mar 2024 | 53,449 | 82,380 (0%) | 0% | 12.6 | 672,923 | Common Stock |
| Viatris Inc | Scott A. Smith | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2024 | 4,898 | 87,278 (0%) | 0% | 0 | Common Stock | |
| Viatris Inc | Scott A. Smith | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2024 | 4,897 | 9,794 | - | - | Dividend Equivalent Units | |
| Viatris Inc | Scott A. Smith | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.59 per share. | 03 Mar 2024 | 1,928 | 85,350 (0%) | 0% | 12.6 | 24,274 | Common Stock |
| BioAtla Inc | A. Scott Smith | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.70 per share. | 29 Feb 2024 | 2,181 | 294,636 | - | 2.7 | 5,889 | Common Stock |
| BioAtla Inc | Scott A. Smith | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.92 per share. | 31 Jan 2024 | 2,181 | 296,817 | - | 1.9 | 4,188 | Common Stock |
| BioAtla Inc | A. Scott Smith | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.46 per share. | 31 Dec 2023 | 1,791 | 298,998 | - | 2.5 | 4,406 | Common Stock |
| BioAtla Inc | Scott A. Smith | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.99 per share. | 31 Jul 2023 | 1,791 | 307,953 | - | 3.0 | 5,355 | Common Stock |
| BioAtla Inc | Scott A. Smith | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.00 per share. | 30 Jun 2023 | 1,791 | 309,744 | - | 3 | 5,373 | Common Stock |
| BioAtla Inc | Scott A. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| BioAtla Inc | Scott A. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 5,895 | 5,895 | - | - | Stock Option (Right to Buy) | |
| BioAtla Inc | Scott A. Smith | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.15 per share. | 31 May 2023 | 1,791 | 311,535 | - | 3.2 | 5,642 | Common Stock |
| BioAtla Inc | Scott A. Smith | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.37 per share. | 30 Apr 2023 | 1,791 | 313,326 | - | 3.4 | 6,036 | Common Stock |
| Viatris Inc | Scott A. Smith | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2023 | 407,485 | 407,485 | - | - | Restricted Stock Units | |
| BioAtla Inc | Scott A. Smith | Director, Former President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.68 per share. | 31 Mar 2023 | 1,791 | 315,117 | - | 2.7 | 4,800 | Common Stock |
| BioAtla Inc | Scott A. Smith | Director, Former President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2023 | 350,000 | 350,000 | - | - | Employee Stock Option (right to buy) | |
| BioAtla Inc | Scott A. Smith | Director, Former President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.98 per share. | 10 Feb 2023 | 1,791 | 316,908 | - | 3.0 | 5,337 | Common Stock |
| BioAtla Inc | Scott A. Smith | Director, President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.79 per share. | 31 Jan 2023 | 2,181 | 318,699 | - | 3.8 | 8,266 | Common Stock |
| BioAtla Inc | Scott A. Smith | Director, President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.25 per share. | 31 Dec 2022 | 1,791 | 320,880 | - | 8.3 | 14,776 | Common Stock |
| BioAtla Inc | Scott A. Smith | Director, President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.01 per share. | 30 Nov 2022 | 1,791 | 322,671 | - | 11.0 | 19,719 | Common Stock |
| BioAtla Inc | Scott A. Smith | Director, President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.89 per share. | 31 Oct 2022 | 1,791 | 324,462 | - | 6.9 | 12,340 | Common Stock |
| BioAtla Inc | Scott A. Smith | Director, President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.70 per share. | 30 Sep 2022 | 1,791 | 326,253 | - | 7.7 | 13,791 | Common Stock |
| BioAtla Inc | Scott A. Smith | Director, President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.71 per share. | 31 Aug 2022 | 1,791 | 328,044 | - | 8.7 | 15,600 | Common Stock |
| BioAtla Inc | Scott A. Smith | Director, President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.40 per share. | 31 Jul 2022 | 1,791 | 329,835 | - | 3.4 | 6,089 | Common Stock |
| BioAtla Inc | Scott A. Smith | Director, President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.85 per share. | 30 Jun 2022 | 1,791 | 331,626 | - | 2.8 | 5,104 | Common Stock |
| BioAtla Inc | Scott A. Smith | Director, President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.41 per share. | 31 May 2022 | 1,791 | 333,417 | - | 2.4 | 4,316 | Common Stock |
| BioAtla Inc | Scott A. Smith | Director, President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.48 per share. | 30 Apr 2022 | 1,791 | 335,208 | - | 3.5 | 6,233 | Common Stock |
| BioAtla Inc | Scott A. Smith | Director, President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.00 per share. | 31 Mar 2022 | 1,791 | 336,999 | - | 5 | 8,955 | Common Stock |
| BioAtla Inc | Scott A. Smith | Director, President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.48 per share. | 28 Feb 2022 | 1,791 | 338,790 | - | 6.5 | 11,606 | Common Stock |
| BioAtla Inc | Scott A. Smith | Director, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 200,000 | 200,000 | - | - | Employee Stock Option (right to buy) | |
| BioAtla Inc | Scott A. Smith | Director, President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.56 per share. | 31 Jan 2022 | 2,181 | 340,581 | - | 9.6 | 20,850 | Common Stock |
| BioAtla Inc | Scott A. Smith | Director, President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.63 per share. | 31 Dec 2021 | 2,894 | 342,762 | - | 19.6 | 56,809 | Common Stock |
| BioAtla Inc | Scott A. Smith | Director, President | Sale of securities on an exchange or to another person at price $ 23.89 per share. | 29 Nov 2021 | 399 | 349,746 | - | 23.9 | 9,532 | Common Stock |
| BioAtla Inc | Scott A. Smith | Director, President | Sale of securities on an exchange or to another person at price $ 24.29 per share. | 22 Nov 2021 | 435 | 350,860 | - | 24.3 | 10,564 | Common Stock |
| BioAtla Inc | Scott A. Smith | Director, President | Sale of securities on an exchange or to another person at price $ 26.23 per share. | 22 Nov 2021 | 430 | 351,295 | - | 26.2 | 11,281 | Common Stock |
| BioAtla Inc | Scott A. Smith | Director, President | Sale of securities on an exchange or to another person at price $ 26.04 per share. | 22 Nov 2021 | 249 | 350,611 | - | 26.0 | 6,483 | Common Stock |
| BioAtla Inc | Scott A. Smith | Director, President | Sale of securities on an exchange or to another person at price $ 24.05 per share. | 22 Nov 2021 | 173 | 350,438 | - | 24.1 | 4,161 | Common Stock |
| BioAtla Inc | Scott A. Smith | Director, President | Sale of securities on an exchange or to another person at price $ 25.00 per share. | 22 Nov 2021 | 160 | 350,278 | - | 25 | 4,000 | Common Stock |
| BioAtla Inc | Scott A. Smith | Director, President | Sale of securities on an exchange or to another person at price $ 25.77 per share. | 22 Nov 2021 | 133 | 350,145 | - | 25.8 | 3,428 | Common Stock |
| BioAtla Inc | Scott A. Smith | Director, President | Sale of securities on an exchange or to another person at price $ 30.18 per share. | 01 Oct 2021 | 2,994 | 351,725 | - | 30.2 | 90,351 | Common Stock |
| BioAtla Inc | Scott A. Smith | Director, President | Sale of securities on an exchange or to another person at price $ 39.63 per share. | 26 Aug 2021 | 19,395 | 368,568 | - | 39.6 | 768,699 | Common Stock |
| BioAtla Inc | Scott A. Smith | Director, President | Sale of securities on an exchange or to another person at price $ 40.89 per share. | 26 Aug 2021 | 13,849 | 354,719 | - | 40.9 | 566,227 | Common Stock |
| BioAtla Inc | Scott A. Smith | Director, President | Other type of transaction at price $ 0.00 per share. | 14 Jun 2021 | 34,963 | 387,963 | - | 0 | Common Stock | |
| BioAtla Inc | Scott A. Smith | Director, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2020 | 154,943 | 154,943 | - | - | Employee Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges